Correction to: Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease

Detalles Bibliográficos
Autores principales: Guja, Cristian, Frías, Juan P., Suchower, Lisa, Hardy, Elise, Marr, Galina, Sjöström, C. David, Jabbour, Serge A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644701/
https://www.ncbi.nlm.nih.gov/pubmed/33011938
http://dx.doi.org/10.1007/s13300-020-00842-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644701/
https://www.ncbi.nlm.nih.gov/pubmed/33011938
http://dx.doi.org/10.1007/s13300-020-00842-w

Ejemplares similares